VNDA
Vanda Pharmaceuticals Inc
Price:  
4.63 
USD
Volume:  
426,055.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA WACC - Weighted Average Cost of Capital

The WACC of Vanda Pharmaceuticals Inc (VNDA) is 7.2%.

The Cost of Equity of Vanda Pharmaceuticals Inc (VNDA) is 10.70%.
The Cost of Debt of Vanda Pharmaceuticals Inc (VNDA) is 5.00%.

Range Selected
Cost of equity 8.90% - 12.50% 10.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 8.1% 7.2%
WACC

VNDA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.1 1.37
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.90% 12.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 8.1%
Selected WACC 7.2%